Once a multibillion dollar company, OvaScience ends a pennystock vehicle for Millendo's reverse merger
An ambitious fertility company plagued by a series of disappointments is playing out its final act — serving as a vehicle for another venture’s success. OvaScience …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.